Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI Completion of a $63.2 million public offering to enable clinical trials of EP-104GI in additional indications Well-capitalized into H2 2028, beyond key catalysts with over $140 million cash VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the first quarter of 2026. “The clinical data reported this quarter further reinforces the potential for EP-104GI to become an important new...

CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) — Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months ended March 31, 2026. Financial Highlights ($000’s except per share data, unaudited)    Three months endedMarch 31      2026     2025   ChangeRevenue   $ 314,896   $ 251,909   25 %Operating income     27,129     26,063   4 %EBITDA(1)     55,158     50,488   9 %Cashflow     54,290     44,934   21 %Net income     24,222     18,952   28 %Attributable to shareholders     24,137     18,966   27 %                 Per Share Data (Diluted)                EBITDA(1)   $ 1.49   $ 1.31   14 %Cashflow   $ 1.46   $ 1.16   26 %                 Attributable to shareholders:                Net income   $ 0.65   $ 0.49   33 %                 Common...

Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2026 gross margin was 77.3%, versus 79.0% in Q1 2025. GAAP Operating Loss was $1.1 million for Q1 2026, a swing of $1.7 million from operating income of $0.6 million in Q1 2025. Company provides guidance for revenue growth of 10-15% for Q2 2026 as compared to Q2 2025EDEN PRAIRIE, Minn., May 12, 2026 (GLOBE NEWSWIRE) — Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial results for the three months ended March 31, 2026. Q1 2026 ended March 31, 2026Revenue for the three months ended March 31, 2026, totaled $9.6 million, an increase of 3.1%,...

VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) reported first quarter 2026 results today. All monetary amounts are in Canadian dollars unless otherwise stated and all financial information in this earnings release represents the results from continuing operations, unless otherwise noted. (1) HIGHLIGHTSAll comparisons are to Q1 2025 results unless indicated otherwise.Revenue of $2.5 billion was up 2%, led by product support growth in Canada. Product support revenue increased 6% with growth across all market sectors. Q1 2026 was the 8th quarter in a row of year-over-year product support growth. SG&A (2) margin (3) was 16.0% and included $15 million of LTIP (2) expense due to strong first quarter share price performance. EBIT...

Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programs Announced publication in Cancer Discovery highlighting preclinical data demonstrating BBO-11818 is a potent and selective pan-KRAS inhibitor Clinical readouts expected in the second half of 2026 across all three programs Cash runway expected to fund operations into 2028SOUTH SAN FRANCISCO, Calif., May 12, 2026 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today reported financial results for the first quarter ended March 31, 2026, and provided a business update, including highlights of pipeline progress. BBOT’s portfolio of late-stage RAS-pathway inhibitors is designed to enable direct dual inhibition...

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2026 and declared a $1.00 per share dividend payable on July 10, 2026 to all common shareholders of record at close of business on June 19, 2026. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated. The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2026 and the accompanying notes, our Management Discussion and Analysis for the three months ended March...

HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) — Evolution Petroleum Corporation (NYSE American: EPM) (“Evolution” or the “Company”) today announced its financial and operating results for its fiscal third quarter ended March 31, 2026. Evolution also declared its 16th consecutive $0.12 cash dividend per common share, payable on June 30, 2026, marking its 51st consecutive quarterly cash dividend payment. Financial & Operational Highlights($ in thousands) Q3 2026 Q3 2025 Q2 2026 % Changevs Q3/Q3 % Changevs Q3/Q2 2026 YTD 2025 YTD % Changevs YTD’25Average BOEPD   6,700     6,667     7,380 —   (9)%     7,135     7,033   1%Revenues $ 20,168   $ 22,561   $ 20,679 (11)%   (2)%   $ 62,135   $ 64,732   (4)%Net Income (Loss)(1) $ (8,932)   $ (2,179)   $ 1,065 310%   NM   $ (7,043)   $ (1,939)   263%Adjusted...

Solana Tokens Held Increased During the Quarter by ~189,000 or 9% (35% Annualized) Digital Asset Revenue Totaled $3.5 Million for the Quarter Conference Call Scheduled for Today, May 12, 2026, at 5:30 p.m. Eastern Time TAMPA, Fla., May 12, 2026 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced its financial results for the fiscal third quarter ended March 31, 2026. “This quarter’s results reflect diligently executing against our digital asset treasury strategy of accumulating SOL on an accretive per-share basis and maintaining a flexible capital structure that positions us to pursue opportunities as they emerge,” said Allan Marshall, Chief Executive Officer of Upexi. “During the quarter, we grew the number...

Revenues: $5.6 million, 21.1% YoY decreaseTransaction Volumes down 32% YoYMore than 1,000 Fold Bitcoin Credit Cards in CirculationRestructuring fees on Bitcoin Gift Card to Drive Distribution PHOENIX, May 12, 2026 (GLOBE NEWSWIRE) — Fold Holdings, Inc. (NASDAQ: FLD) (“Fold”, “we”, or “our”), the first publicly traded bitcoin financial services company, today announced financial results for the first quarter ended March 31, 2026. Q1 2026 Financial HighlightsRevenue: $5.6 million; 21.1% YoY decrease Net Loss: ($29.2) million Adjusted EBITDA2 (Loss): ($5.8) million Loss Per Share: ($0.59) per share Adjusted EBITDA (Loss) Per Share2: ($0.12) per share Bitcoin Investment Treasury Holdings1: 826 BTCQ1 2026 Key Operating MetricsTotal Transaction Volume: $172 million; 32% YoY decrease Total Verified Accounts: nearly 85,000, added...

CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces first quarter results for the period ended March 31, 2026. First Quarter HighlightsTotal production of 15,533 boe/d(1) including crude oil and natural gas liquids production of 10,136 bbls/d, representing a 65% liquids weighting in the quarter; Revenue of $78 million with crude oil and natural gas liquids production accounting for approximately 90% of total revenue; Funds from operations of $59 million ($0.36/share) (2)(4); Returned $44 million ($0.27/share)(3) to shareholders through monthly dividends; Invested $19 million to acquire strategic, inventory rich, royalty interest lands in the core of the Permian basin; and Drilling in the quarter was focused on crude oil targets with 223 wells (4.9 net) drilled.President’s...